Vol. 41 No. 1 (2024): Febrero
Review Article

Clinical trials of superiority, non-inferiority or equivalence?

Carlos Manterola
Universidad de La Frontera, Chile.
Bio
Tamara Otzen
Universidad de La Frontera, Chile.
Bio
María José Hernández-Leal
Universidad de La Frontera, Chile.
Bio
Juan Pablo Holguín
Programa de Doctorado en Ciencias Médicas, Universidad de La Frontera, Chile. Universidad del Azuay, Ecuador.
Bio
Carla Salgado
Programa de Doctorado en Ciencias Médicas, Universidad de La Frontera, Chile. Universidad del Azuay, Ecuador.
Bio
Luis Grande
Universitat Autònoma de Barcelona, España. Servicio de Cirugía, Hospital del Mar, Barcelona, España.
Bio
Josue Rivadeneira
Universidad de La Frontera
Bio
Revista Chilena de Infectologia - febrero 2024

Published 2024-02-02

How to Cite

1.
Manterola C, Otzen T, Hernández-Leal MJ, Holguín JP, Salgado C, Grande L, Rivadeneira J. Clinical trials of superiority, non-inferiority or equivalence?. Rev. Chilena. Infectol. [Internet]. 2024 Feb. 2 [cited 2025 Nov. 27];41(1). Available from: https://www.revinf.cl/index.php/revinf/article/view/2024000100157

Abstract

Efficacy and effectivity of new interventions are generally established through randomized clinical trials (RCTs). However, among many other methodological challenges, specifying the hypothesis of a RCT remains complex problem for clinical researchers.In this manuscript we discuss the characteristics of three variants of RCTs: superiority RCT (SRCT), non-inferiority RCT (NIRCT), and equivalence RCT (ERCT). These three types of RCT have different assumptions about the effects of an intervention, so setting hypotheses and defining objectives requires knowing some assumptions underlying these RCTs, including elements related to the estimation of the sample size for each one. The aim of this manuscript was to describe methodological differences between SRCT, NIRCT and ERCT.